Sustainable Drug Discovery and Development with End-of-Life Yield

Akronym

SUDDEN

Bidragets beskrivning

The ecological risks related to pharmaceutical emissions are an increasing concern both locally and globally. Hormonal and antibiotic residues are particularly harmful even at very low concentrations. Current societal transformations incl. urbanization, population growth and ageing, contribute to the accumulation of pharmaceuticals in the environment at an accelerated pace. The SUDDEN project tackles the environmental hazards and sustainability challenges related to drug manufacturing, consumption, and end-of-life. The project aims to enhance the benign-by-design drug discovery, bridge the gaps in the legal framework of global production chains of pharmaceuticals, redesign modern wastewater purification and reuse of the sewage sludge, and introduce circular economy models to pharmaceutical packaging materials with a view to developing a Life Cycle Impact Assessment model to drug products and supporting the economic growth of sustainable pharmaceutical industry and services in Finland.
Visa mer

Startår

2022

Slutår

2023

Beviljade finansiering





Jari Yli-Kauhaluoma Orcid -palvelun logo
750 473 €


Rollen i Finlands Akademis konsortium

Övriga parter i konsortiet

Partner
Lappeenrannan–Lahden teknillinen yliopisto LUT (346569)
210 951 €
Partner
Aalto-universitetet (346570)
175 662 €
Partner
Östra Finlands universitet (346571)
350 325 €
Partner
Finlands miljöcentral (346572)
176 233 €
Partner
(346573)
170 444 €

Finansiär

Finlands Akademi

Typ av finansiering

Finansiering för strategisk forskning

Övriga uppgifter

Finansieringsbeslutets nummer

346568

Vetenskapsområden

Farmaci

Forskningsområden

Farmasia

Temaområden

Uudistu tai surkastu - resurssit ja ratkaisut

Identifierade teman

pharmacy, biomedicine